News and Publications

  • Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening

    ARCHIMEDlife News , Publications November 1, 2012
    The interest in early detection strategies for lysosomal storage disorders (LSDs) in newborns and high-risk population has increased in the last years due to the… Read more
  • Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL

    ARCHIMEDlife News , Publications October 22, 2012

    The P2RY8-CRLF2 fusion defines a particular relapse-prone subset of childhood ALL in AIEOP-BFM 2000 protocols. To investigate whether and to what extent different clone sizes… Read more

  • Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine

    Publications August 16, 2012
    Abstract: Newborn screening for tyrosinemia type I (Tyr-I) is mandatory to identify infants at risk before life-threatening symptoms occur. The analysis of tyrosine alone is… Read more
  • The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis

    ARCHIMEDlife News , Publications February 23, 2012
    Background: To determine the predictive value of the immature granulocyte count and the immature myeloid information in neonatal early onset sepsis we examined 133 blood samples… Read more
  • Neonatal screening for lysosomal storage disorders: Feasibility and incidence from a nationwide study in Austria

    ARCHIMEDlife News , Publications November 29, 2011
    Background: The interest in neonatal screening for lysosomal storage disorders has increased substantially because of newly developed enzyme replacement therapies, the need for early diagnosis,… Read more
  • Simplified newborn screening protocol for lysosomal storage disorders

    ARCHIMEDlife News , Publications September 1, 2011
    BACKGROUND: Interest in lysosomal storage disorders, a collection of more than 40 inherited metabolic disorders, has increased because of new therapy options such as enzyme replacement,… Read more